Takeda Pharmaceutical
Tokyo, M0files as TAKEDA PHARMACEUTICAL CO LTD
$16m in 8 US stocks at the end of 30 September 2025. The top 10 are 100.0% of the money. It changed about 71.7% of the portfolio this quarter.
Value
$16m
Stocks
8
Top 10 share
100.0%
Turnover
71.7%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- Lyell ImmunopharmaLYEL5.4% of the fund+33%
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- Hillevax-100%
- Turnstone Biologics-100%
- Third Harmonic BIO INC.com-100%
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Ovid TherapeuticsOVID | 59.8% | $10m | 7,531,996 | Held |
| EquilliumEQ | 15.9% | $3m | 1,824,977 | Held |
| Xilio TherapeuticsXLO | 7.6% | $1m | 1,475,121 | Held |
| Shattuck LabsSTTK | 7.5% | $1m | 515,619 | Held |
| Lyell ImmunopharmaLYEL | 5.4% | $891,365 | 54,887 | +33% |
| American WellAMWL | 2.9% | $478,061 | 77,733 | Held |
| Rani Therapeutics HoldingsRANI | 0.6% | $101,554 | 203,190 | Held |
| Standard BiotoolsLAB | 0.1% | $21,470 | 16,515 | Held |
Over time and by industry
Value over time
Sep '25
Value is down 16.3% since 30 June 2025.
Where the money is
Health care97.1%
Technology2.9%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.